Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
DATROWAY Pulver 100 mg 1 Stk
Drug
DATROWAY, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Brustkrebs
07.16.1. – cytostatics
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
5/28/2025
5/27/2030
Dosage strength
DATROWAY 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Brustkrebs
01
Z – approved
Package
7680698010012
In trade from / since 7/28/2025
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
100 mg datopotamabum deruxtecanum
saccharum
histidinum
histidini hydrochloridum monohydricum
polysorbatum 80
histidinum
histidini hydrochloridum monohydricum
polysorbatum 80
Authorisation holder
7601001308855
Daiichi Sankyo (Schweiz) AG
Vulkanstrasse 106
8048 Zürich (ZH)
Vulkanstrasse 106
8048 Zürich (ZH)
Date of revision of the text
7/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.